The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Martineau, A. R., Jolliffe, D. A., Hooper, R. L., Greenberg, L., Aloia, J. F., Bergman, P., Dubnov-Raz, G., Esposito, S., Ganmaa, D., Ginde, A. A., et al. (2017) · BMJ · doi:10.1136/bmj.i6583 · Cited by 2,040 · cited 1×
“In contrast, vitamin D supplementation can prevent respiratory infections through several immunoregulatory functions, including the reduced production of proinflammatory cytokines by the innate immune system [63].”
BackgroundLee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
Obesity and the skin: Skin physiology and skin manifestations of obesity
Yosipovitch, G., DeVore, A., & Dawn, A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.12.004 · Cited by 524 · cited 2×
“This progressive accumulation of fluid results in reduced tissue oxygenation, which can cause fibrosis and a chronic inflammatory state over time [76].”
Backgroundde Jongh, R. T., Serné, E. H., IJzerman, R. G., de Vries, G., & Stehouwer, C. D. A. (2004) · Circulation · doi:10.1161/01.cir.0000129772.26647.6f · Cited by 407
Trischitta, V., Brunetti, A., Chiavetta, A., Benzi, L., Papa, V., & Vigneri, R. (1989) · Diabetes · doi:10.2337/diab.38.12.1579 · Cited by 61
Research works printed but not linked: 143
- Huttunen R, Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37:333–40. · DOI · Paper page
- Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev. 2011;12:653–9. · DOI · Paper page
- Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8:e1001053. · DOI · Paper page
- Murphy R, Fragaszy EB, Hayward AC, Warren-Gash C. Investigating obesity as a risk factor for influenza-like illness during the 2009 H1N1 influenza pandemic using the Health Survey for England. Influenza Other Respir Viruses. 2017;11:66–73. · DOI
- Kim CO, Nam CM, Lee DC, Chang J, Lee JW. Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school-aged children? Influenza Other Respir Viruses. 2012;6:313–7. · DOI
- Bijani B, Pahlevan AA, Qasemi-Barqi R, Jahanihashemi H. Metabolic syndrome as an independent risk factor of hypoxaemia in influenza A (H1N1) 2009 pandemic. Infez Med. 2016;24:123–30.
- Bochicchio GV, Joshi M, Bochicchio K, Nehman S, Tracy JK, Scalea TM. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg. 2006;203:533–8. · DOI · Paper page
- Wurzinger B, Dunser MW, Wohlmuth C, Deutinger MC, Ulmer H, Torgersen C, et al. The association between body-mass index and patient outcome in septic shock: a retrospective cohort study. Wien Klin Wochenschr. 2010;122:31–6. · DOI
- Basu JK, Jeketera CM, Basu D. Obesity and its outcomes among pregnant South African women. Int J Gynaecol Obstet. 2010;110:101–4. · DOI
- Usha Kiran TS, Hemmadi S, Bethel J, Evans J. Outcome of pregnancy in a woman with an increased body mass index. BJOG. 2005;112:768–72. · DOI · Paper page
- Choban PS, Heckler R, Burge JC, Flancbaum L. Increased incidence of nosocomial infections in obese surgical patients. Am Surg. 1995;61:1001–5.
- Kaye KS, Marchaim D, Chen TY, Chopra T, Anderson DJ, Choi Y, et al. Predictors of nosocomial bloodstream infections in older adults. J Am Geriatr Soc. 2011;59:622–7. · DOI
- Olsen MA, Higham-Kessler J, Yokoe DS, Butler AM, Vostok J, Stevenson KB, et al. Developing a risk stratification model for surgical site infection after abdominal hysterectomy. Infect Control Hosp Epidemiol. 2009;30:1077–83. · DOI
- Waisbren E, Rosen H, Bader AM, Lipsitz SR, Rogers SO Jr., Eriksson E. Percent body fat and prediction of surgical site infection. J Am Coll Surg. 2010;210:381–9. · DOI · Paper page
- Di Leo A, Piffer S, Ricci F, Manzi A, Poggi E, Porretto V, et al. Surgical site infections in an Italian surgical ward: a prospective study. Surg Infect (Larchmt). 2009;10:533–8. · doi:10.1089/sur.2009.008
- Beldi G, Bisch-Knaden S, Banz V, Muhlemann K, Candinas D. Impact of intraoperative behavior on surgical site infections. Am J Surg. 2009;198:157–62. · DOI
- Towfigh S, Chen F, Katkhouda N, Kelso R, Sohn H, Berne TV, et al. Obesity should not influence the management of appendicitis. Surg Endosc. 2008;22:2601–5. · DOI
- Zahr F, Genovese E, Mathier M, Shullo M, Lockard K, Zomak R, et al. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. Ann Thorac Surg. 2011;92:1420–6. · DOI
- Torgerson JS, Lindroos AK, Naslund I, Peltonen M. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol. 2003;98:1032–41.
- Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206–9. · DOI · Paper page
- Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010;16:729–34. · doi:10.1111/j.1469-0691.2009.02906.x
- Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215:118–22. · doi:10.1159/000104262
- Carratala J, Roson B, Fernandez-Sabe N, Shaw E, del Rio O, Rivera A, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22:151–7. · DOI · Paper page
- Lo Iacono O, Venezia G, Petta S, Mineo C, De Lisi S, Di, Marco V, et al. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2007;25:1181–91. · DOI
- Harpsoe MC, Nielsen NM, Friis-Moller N, Andersson M, Wohlfahrt J, Linneberg A, et al. Body mass index and risk of infections among women in the Danish National Birth Cohort. Am J Epidemiol. 2016;183:1008–17. · DOI
- Phung DT, Wang Z, Rutherford S, Huang C, Chu C. Body mass index and risk of pneumonia: a systematic review and meta-analysis. Obes Rev. 2013;14:839–57. · DOI
- Dorner TE, Schwarz F, Kranz A, Freidl W, Rieder A, Gisinger C. Body mass index and the risk of infections in institutionalised geriatric patients. Br J Nutr. 2010;103:1830–5. · DOI
- Nave H, Beutel G, Kielstein JT. Obesity-related immunodeficiency in patients with pandemic influenza H1N1. Lancet Infect Dis. 2011;11:14–5. · DOI
- Muscogiuri G, Pugliese G, Laudisio D, Castellucci B, Barrea L, Savastano S, et al. The impact of obesity on immune response to infection: plausible mechanisms and outcomes. Obes Rev. 2021;22:e13216. · DOI
- Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–83. · DOI · Paper page
- Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem. 1994;269:17001–4. · DOI · Paper page
- Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897–901. · DOI · Paper page
- Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol. 2006;176:7745–52. · DOI · Paper page
- Caldefie-Chezet F, Poulin A, Tridon A, Sion B, Vasson MP. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J Leukoc Biol. 2001;69:414–8. · DOI · Paper page
- Claycombe K, King LE, Fraker PJ. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci USA. 2008;105:2017–21. · DOI · Paper page
- Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000;199:15–24. · DOI · Paper page
- Stentz FB, Kitabchi AE. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4:493–503. · DOI
- Stentz FB, Kitabchi AE. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem Biophys Res Commun. 2005;335:491–5. · DOI
- Frydrych LM, Bian G, O’Lone DE, Ward PA, Delano MJ. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104:525–34. · DOI · Paper page
- Torres-Castro I, Arroyo-Camarena UD, Martinez-Reyes CP, Gomez-Arauz AY, Duenas-Andrade Y, Hernandez-Ruiz J, et al. Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose. Immunol Lett. 2016;176:81–9. · DOI · Paper page
- Brotfain E, Hadad N, Shapira Y, Avinoah E, Zlotnik A, Raichel L, et al. Neutrophil functions in morbidly obese subjects. Clin Exp Immunol. 2015;181:156–63. · DOI
- Wensveen FM, Jelencic V, Valentic S, Sestan M, Wensveen TT, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376–85. · DOI · Paper page
- Fay NS, Larson EC, Jameson JM. Chronic Inflammation and gammadelta T Cells. Front Immunol. 2016;7:210.
- Xia C, Rao X, Zhong J. Role of T lymphocytes in Type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017;2017:6494795.
- Wagner NM, Brandhorst G, Czepluch F, Lankeit M, Eberle C, Herzberg S, et al. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring). 2013;21:461–8. · DOI · Paper page
- Frikke-Schmidt H, Zamarron BF, O’Rourke RW, Sandoval DA, Lumeng CN, Seeley RJ. Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice. Mol Metab. 2017;6:317–26. · DOI
- Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care. 2017;5:e000379. · DOI · Paper page
- Christou KA, Christou GA, Karamoutsios A, Vartholomatos G, Gartzonika K, Tsatsoulis A, et al. Metabolically healthy obesity is characterized by a proinflammatory phenotype of circulating monocyte subsets. Metab Syndr Relat Disord. 2019;17:259–65. · doi:10.1089/met.2018.0132
- Barrea L, Frias-Toral E, Pugliese G, Garcia-Velasquez E, DELAC M, Savastano S, et al. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinol (Torino). 2021;46:177–92.
- Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40:1109–51. · DOI · Paper page
- Barrea L, Muscogiuri G, Frias-Toral E, Laudisio D, Pugliese G, Castellucci B, et al. Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota. Crit Rev Food Sci Nutr. 2021;61:3066–90. · DOI · Paper page
- Muscogiuri G, Barrea L, Savastano S, Colao A. Nutritional recommendations for CoVID-19 quarantine. Eur J Clin Nutr. 2020;74:850–1. · DOI · Paper page
- Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015;16:341–9. · DOI · Paper page
- Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf). 2012;76:315–25. · DOI · Paper page
- Kuo YT, Kuo CH, Lam KP, Chu YT, Wang WL, Huang CH, et al. Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes. J Food Sci. 2010;75:H200–4. · DOI
- Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine. 1992;4:506–12. · DOI · Paper page
- Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634–47. · DOI · Paper page
- Willheim M, Thien R, Schrattbauer K, Bajna E, Holub M, Gruber R, et al. Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab. 1999;84:3739–44.
- Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132:1146–60. · DOI · Paper page
- Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169:384–90. · DOI · Paper page
- Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321:249–79. · DOI · Paper page
- Holley HS, Milic-Emili J, Becklake MR, Bates DV. Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest. 1967;46:475–81. · DOI · Paper page
- Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128:501–6. · DOI · Paper page
- Shailaja S, Nichelle SM, Shetty AK, Hegde BR. Comparing ease of intubation in obese and lean patients using intubation difficulty scale. Anesth Essays Res. 2014;8:168–74. · DOI
- Light RB. Pulmonary pathophysiology of pneumococcal pneumonia. Semin Respir Infect. 1999;14:218–26.
- Cheong HS, Chang Y, Joo EJ, Cho A, Ryu S. Metabolic obesity phenotypes and risk of cellulitis: a cohort study. J Clin Med. 2019;8:953. https://doi.org/10.3390/jcm8070953. · DOI
- Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999;318:1591–4. · DOI · Paper page
- Valensi P, Smagghue O, Paries J, Velayoudon P, Lormeau B, Attali JR. Impairment of skin vasoconstrictive response to sympathetic activation in obese patients: influence of rheological disorders. Metabolism. 2000;49:600–6. · DOI
- Carlson JA. Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infection, inflammatory dermatoses, and neoplasia: a locus minoris resistentiae. Clin Dermatol. 2014;32:599–615. · DOI
- Greene AK, Zurakowski D, Goss JA. Body mass index and lymphedema morbidity: comparison of obese versus normal-weight patients. Plast Reconstr Surg. 2020;146:402–7. · DOI
- Schramm JC, Dinh T, Veves A. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006;5:149–59. · DOI
- Bui UT, Finlayson K, Edwards H. Validation of predictive factors for infection in adults with chronic leg ulcers: a prospective longitudinal study. J Clin Nurs. 2020;29:1074–84. · DOI
- Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–33. · DOI · Paper page
- Klekotka RB, Mizgala E, Krol W. The etiology of lower respiratory tract infections in people with diabetes. Pneumonol Alergol Pol. 2015;83:401–8. · DOI
- Plaeke P, De Man JG, Coenen S, Jorens PG, De Winter BY, Hubens G. Clinical- and surgery-specific risk factors for post-operative sepsis: a systematic review and meta-analysis of over 30 million patients. Surg Today. 2020;50:427–39. · doi:10.1007/s00595-019-01827-4
- Jain R, Chung SM, Jain L, Khurana M, Lau SW, Lee JE, et al. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther. 2011;90:77–89. · DOI · Paper page
- Roe JL, Fuentes JM, Mullins ME. Underdosing of common antibiotics for obese patients in the ED. Am J Emerg Med. 2012;30:1212–4. · DOI
- Zhang LJ, Guerrero-Juarez CF, Chen SX, Zhang X, Yin M, Li F. Diet-induced obesity promotes infection by impairment of the innate antimicrobial defense function of dermal adipocyte progenitors. Sci Transl Med. 2021;13:eabb5280. https://doi.org/10.1126/scitranslmed.abb5280. · DOI
- Cannon J, Rajakaruna G, Dyer J, Carapetis J, Manning L. Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. Clin Microbiol Infect. 2018;24:1089–94. · DOI
- Kozlowska D, Mysliwiec H, Kiluk P, Baran A, Milewska AJ, Flisiak I. Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelas. Przegl Epidemiol. 2016;70:575–84.
- Rob F, Hercogova J. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients. J Dermatolog Treat. 2018;29:39–43. · DOI
- Shipman AR, Millington GW. Obesity and the skin. Br J Dermatol. 2011;165:743–50. · DOI
- Metin A, Dilek N, Bilgili SG. Recurrent candidal intertrigo: challenges and solutions. Clin Cosmet Investig Dermatol. 2018;11:175–85. · DOI
- Doner NYS, Ekmekci TR. Evaluation of obesity-associated dermatoses in obese and overweight individuals. Turkderm. 2011;45:146–51. · DOI
- Chan MK, Chong LY, Achilles Project Working Group in Hong K. A prospective epidemiologic survey on the prevalence of foot disease in Hong Kong. J Am Podiatr Med Assoc. 2002;92:450–6. · DOI
- Mirmirani P, Carpenter DM. Skin disorders associated with obesity in children and adolescents: a population-based study. Pediatr Dermatol. 2014;31:183–90. · DOI
- Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219:40–51. · DOI · Paper page
- Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17:227–41. · DOI · Paper page
- Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151:1194–205. · DOI · Paper page
- Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The impact of obesity on urinary tract infection risk. Urology. 2012;79:266–9. · DOI
- Shill MC, Huda NH, Moain FB, Karmakar UK. Prevalence of uropathogens in diabetic patients and their corresponding resistance pattern: results of a survey conducted at diagnostic centers in dhaka, bangladesh. Oman Med J. 2010;25:282–5.
- Bamgbade OA, Rutter TW, Nafiu OO, Dorje P. Postoperative complications in obese and nonobese patients. World J Surg. 2007;31:556–60. discussion 61 · DOI · Paper page
- Saliba W, Barnett-Griness O, Rennert G. The association between obesity and urinary tract infection. Eur J Intern Med. 2013;24:127–31. · doi:10.1016/j.ejim.2012.11.006
- Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, Moller BK, et al. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology. 2015;26:580–9. · DOI
- Nseir W, Farah R, Mahamid M, Sayed-Ahmad H, Mograbi J, Taha M, et al. Obesity and recurrent urinary tract infections in premenopausal women: a retrospective study. Int J Infect Dis. 2015;41:32–5. · DOI
- Grier WR, Kratimenos P, Singh S, Guaghan JP, Koutroulis I. Obesity as a risk factor for urinary tract infection in children. Clin Pediatr (Phila). 2016;55:952–6. · doi:10.1177/0009922815617974
- Hsu PC, Chen SJ. Obesity and risk of urinary tract infection in young children presenting with fever. Medicine (Baltimore). 2018;97:e13006. · DOI
- Okubo Y, Handa A. The impact of obesity on pediatric inpatients with urinary tract infections in the United States. J Pediatr Urol. 2017;13:455 e1–e5. · DOI
- Zasloff M. Why are diabetics prone to kidney infections? J Clin Invest. 2018;128:5213–5. · DOI
- Eichler TE, Becknell B, Easterling RS, Ingraham SE, Cohen DM, Schwaderer AL, et al. Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract. Kidney Int. 2016;90:568–79. · DOI
- Murtha MJ, Eichler T, Bender K, Metheny J, Li B, Schwaderer AL, et al. Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses. J Clin Invest. 2018;128:5634–46. · DOI
- Kim JW, Lee YJ, Ha YS, Lee JN, Kim HT, Chun SY, et al. Secondary signs on preoperative CT as predictive factors for febrile urinary tract infection after ureteroscopic lithotripsy. BMC Urol. 2020;20:131.
- Petersen A, Bressem K, Albrecht J, Thiess HM, Vahldiek J, Hamm B, et al. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. 2020;110:154317. · DOI · Paper page
- Di Bella S, Cesareo R, De Cristofaro P, Palermo A, Sanson G, Roman-Pognuz E, et al. Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: a multicentric prospective evaluation. Diabetes Metab Res Rev. 2021;37:e3354. · DOI
- Bergmann BM, Seiden LS, Landis CA, Gilliland MA, Rechtschaffen A. Sleep deprivation in the rat: XVIII. Regional brain levels of monoamines and their metabolites. Sleep. 1994;17:583–9. · DOI
- Pinheiro TA, Barcala-Jorge AS, Andrade JMO, Pinheiro TA, Ferreira ECN, Crespo TS, et al. Obesity and malnutrition similarly alter the renin-angiotensin system and inflammation in mice and human adipose. J Nutr Biochem. 2017;48:74–82. · DOI
- Al Heialy S, Hachim MY, Senok A, Gaudet M, Abou Tayoun A, Hamoudi R, et al. Regulation of angiotensin-converting enzyme 2 in obesity: implications for COVID-19. Front Physiol. 2020;11:555039. · DOI
- Li L, Spranger L, Soll D, Beer F, Brachs M, Spranger J, et al. Metabolic impact of weight loss induced reduction of adipose ACE-2—potential implication in COVID-19 infections? Metabolism. 2020;113:154401. · DOI
- Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. 2020;19:100283. · DOI · Paper page
- Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis. 2011;52:301–12. · DOI · Paper page
- Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE. 2010;5:e9694. · DOI · Paper page
- Campitelli MA, Rosella LC, Kwong JC. The association between obesity and outpatient visits for acute respiratory infections in Ontario, Canada. Int J Obes (Lond). 2014;38:113–9. · DOI
- Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med. 2000;160:3082–8. · DOI · Paper page
- Karunanayake CP, Rennie DC, Ramsden VR, Fenton M, Kirychuk S, Lawson JA, et al. Bronchitis and its associated risk factors in first nations children. Children (Basel). 2017;4:103. https://doi.org/10.3390/children4120103. · doi:10.3390/children4120103
- Lee YL, Chen YC, Chen YA. Obesity and the occurrence of bronchitis in adolescents. Obesity (Silver Spring). 2013;21:E149–53. · doi:10.1002/oby.20262
- Maccioni L, Weber S, Elgizouli M, Stoehlker AS, Geist I, Peter HH, et al. Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health. 2018;18:271. · DOI
- Okubo Y, Nochioka K, Testa MA. The impact of pediatric obesity on hospitalized children with lower respiratory tract infections in the United States. Clin Respir J. 2018;12:1479–84. · DOI
- Pahwa P, Karunanayake CP, Rennie DC, Lawson JA, Ramsden VR, McMullin K, et al. Prevalence and associated risk factors of chronic bronchitis in First Nations people. BMC Pulm Med. 2017;17:95. · DOI · Paper page
- Diaz E, Rodriguez A, Martin-Loeches I, Lorente L, Del Mar Martin M, Pozo JC, et al. Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest. 2011;139:382–6. · DOI
- Viasus D, Pano-Pardo JR, Pachon J, Campins A, Lopez-Medrano F, Villoslada A, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect. 2011;17:738–46. · DOI
- Coleman LA, Waring SC, Irving SA, Vandermause M, Shay DK, Belongia EA. Evaluation of obesity as an independent risk factor for medically attended laboratory-confirmed influenza. Influenza Other Respir Viruses. 2013;7:160–7. · DOI
- Gottrup FMA, Hollander DA. An overview of surgical site infections: aetiology, 375 incidence and risk factors. EWMA J. 2005;5:11–5 376.
- Pinkney TD, Calvert M, Bartlett DC, Gheorghe A, Redman V, Dowswell G, et al. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). BMJ. 2013;347:f4305. · DOI · Paper page
- O’Keeffe AB, Lawrence T, Bojanic S. Oxford craniotomy infections database: a cost analysis of craniotomy infection. Br J Neurosurg. 2012;26:265–9. · doi:10.3109/02688697.2011.626878
- Abbey M, Triantafilidis C, Topping DL. Dietary non-starch polysaccharides interact with cholesterol and fish oil in their effects on plasma lipids and hepatic lipoprotein receptor activity in rats. J Nutr. 1993;123:900–8. · doi:10.1093/jn/123.5.900
- Ketonen J, Pilvi T, Mervaala E. Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice. Heart Vessels. 2010;25:254–62. · DOI
- Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:CD003641.
- Savastano S, Di Somma C, Pivonello R, Tarantino G, Orio F, Nedi V, et al. Endocrine changes (beyond diabetes) after bariatric surgery in adult life. J Endocrinol Invest. 2013;36:267–79.
- Kakarla VR, Nandipati K, Lalla M, Castro A, Merola S. Are laparoscopic bariatric procedures safe in superobese (BMI >/=50 kg/m2) patients? An NSQIP data analysis. Surg Obes Relat Dis. 2011;7:452–8. · DOI
- Ferraz AAB, Vasconcelos CFM, Santa-Cruz F, Aquino MAR, Buenos-Aires VG, Siqueira LT. Surgical site infection in bariatric surgery: results of a care bundle. Rev Col Bras Cir. 2019;46:e2252. · DOI
- Gendall KA, Raniga S, Kennedy R, Frizelle FA. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum. 2007;50:2223–37. · DOI · Paper page
- Lee DW, Han SW, Cha Y, Lee KH, Kim TY, Oh DY, et al. Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients. BMC Cancer. 2015;15:690.
- Wahl TS, Patel FC, Goss LE, Chu DI, Grams J, Morris MS. The obese colorectal surgery patient: surgical site infection and outcomes. Dis Colon Rectum. 2018;61:938–45. · DOI
- Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208:53–61. · DOI · Paper page
- Healy LA, Ryan AM, Sutton E, Younger K, Mehigan B, Stephens R, et al. Impact of obesity on surgical and oncological outcomes in the management of colorectal cancer. Int J Colorectal Dis. 2010;25:1293–9. · DOI
- Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Yatabe T, Maeda H, et al. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect. 2009;73:47–53. · DOI
- Gervaz P, Bandiera-Clerc C, Buchs NC, Eisenring MC, Troillet N, Perneger T, et al. Scoring system to predict the risk of surgical-site infection after colorectal resection. Br J Surg. 2012;99:589–95. · doi:10.1002/bjs.8656
- Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol. 2011;18:2126–35. · DOI · Paper page
- Su Z, Koga R, Saiura A, Natori T, Yamaguchi T, Yamamoto J. Factors influencing infectious complications after pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2010;17:174–9. · doi:10.1007/s00534-009-0128-0
- Figuerola-Tejerina A, Rodriguez-Caravaca G, Bustamante-Munguira J, Maria San Roman-Montero J, Duran-Poveda M. Epidemiological surveillance of surgical site infection and its risk factors in cardiac surgery: a prospective cohort study. Rev Esp Cardiol (Engl Ed). 2016;69:842–8. · doi:10.1016/j.recesp.2016.01.031
- Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG Jr, Sexton DJ, et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004;38:1555–60. · DOI
- Lu K, Zhang J, Cheng J, Liu H, Yang C, Yin L, et al. Incidence and risk factors for surgical site infection after open reduction and internal fixation of intra-articular fractures of distal femur: a multicentre study. Int Wound J. 2019;16:473–8. · DOI
- Dias M, Dick A, Reynolds RM, Lahti-Pulkkinen M, Denison FC. Predictors of surgical site skin infection and clinical outcome at caesarean section in the very severely obese: a retrospective cohort study. PLoS ONE. 2019;14:e0216157. · DOI
Cited by
Ng, M., Gakidou, E., Lo, J., Abate, Y. H., Abbafati, C., Abbas, N., Abbasian, M., Abd ElHafeez, S., Abdel-Rahman, W. M., Abd-Elsalam, S., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00355-1 · Cited by 1,151
“60 Overall, the disease burden associated with NCDs has risen considerably in many LMICs in the past 30 years.”
Morales, F., Montserrat-de la Paz, S., Leon, M. J., & Rivero-Pino, F. (2023) · Nutrients · doi:10.3390/nu16010001 · Cited by 346
Rohani, P., Malekpour Alamdari, N., Bagheri, S. E., Hekmatdoost, A., & Sohouli, M. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230206 · Cited by 18
Recent research advances in metabolism, clinical and experimental
Boutari, C., Kokkorakis, M., Stefanakis, K., Valenzuela-Vallejo, L., Axarloglou, E., Volčanšek, Š., Chakhtoura, M., & Mantzoros, C. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155722 · Cited by 9
Metadata
- Authors
- Pugliese, G., Liccardi, A., Graziadio, C., Barrea, L., Muscogiuri, G., & Colao, A.
- Venue
- International Journal of Obesity
- Published
- 2022-01-21
- Volume
- 46
- Issue
- 3
- Pages
- 449-465
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W4205824122
- Cited by
- 207
- References
- 7
- FWCI
- 34.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. https://app.cochat.ai/papers/10.1038/s41366-021-01035-6
- The paper
- Pugliese, G., Liccardi, A., Graziadio, C., Barrea, L., Muscogiuri, G., & Colao, A. (2022). Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. International Journal of Obesity. https://doi.org/10.1038/s41366-021-01035-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.